Metabolomic profile as a biomarker in early breast cancer patients candidate to neoadjuvant therapy

被引：0
|
作者：
Martini, V. [1 ]
Ruffilli, B. [2 ]
Di Lascio, S. [1 ]
D'Avanzo, F. [1 ]
Rossi, V. [1 ]
Gobbato, S. [2 ]
Vezzoli, F. [2 ]
Negrini, L. [2 ]
Alsati, R. [2 ]
Ben Ayed, R. [2 ]
Tarantino, G. [3 ]
Guarneri, V. [4 ]
Griguolo, G. [4 ]
Boldorini, R. L. [2 ]
Branni, C. [2 ]
Matera, L. [2 ]
Sala, N. [2 ]
Barberis, E. [2 ]
Manfredi, M. [2 ]
Gennari, A. [2 ]
机构：
[1] AOU Maggiore Carita, Dept Oncol, Novara, Italy
[2] Univ Piemonte Orientale, Translat Med, Novara, Italy
[3] Pharmanutra Spa, Pisa, Italy
[4] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113874
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
308 (PB-12
引用
收藏
页码：115 / 115
页数：1
相关论文
共 50 条
  • [1] Effect of neoadjuvant therapy on breast cancer biomarker profile
    Rey-Vargas, Laura
    Carlos Mejia-Henao, Juan
    Carolina Sanabria-Salas, Maria
    Serrano-Gomez, Silvia J.
    BMC CANCER, 2020, 20 (01)
  • [2] Effect of neoadjuvant therapy on breast cancer biomarker profile
    Laura Rey-Vargas
    Juan Carlos Mejía-Henao
    María Carolina Sanabria-Salas
    Silvia J. Serrano-Gomez
    BMC Cancer, 20
  • [3] Metabolomic profiling and response to neoadjuvant therapy (NAT) in early breast cancer (EBC)
    Gennari, A.
    Barberis, E.
    Martini, V.
    Gobbato, S.
    Alsati, R.
    Ben Ayed, R.
    Rossi, V.
    D'Avanzo, F.
    Ruffilli, B.
    Malagutti, B.
    Dodaro, I.
    Gallarotti, E.
    Galli, L.
    Boldorini, R.
    Gambaro, A.
    Rampi, A.
    Branni, C.
    Manfredi, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S300 - S300
  • [4] Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer
    Juliachs, Merce
    Pujals, Mireia
    Bellio, Chiara
    Meo-Evoli, Nathalie
    Duran, Juan M.
    Zamora, Esther
    Pares, Mireia
    Sunol, Anna
    Mendez, Olga
    Sanchez-Pla, Alex
    Canals, Francesc
    Saura, Cristina
    Villanueva, Josep
    CANCERS, 2022, 14 (16)
  • [5] Targets for Neoadjuvant Therapy - The Preferences of Patients with Early Breast Cancer
    Thill, M.
    Pisa, G.
    Isbary, G.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2016, 76 (05) : 551 - 556
  • [6] Metabolomic profiling and response to neoadjuvant therapy in operable breast cancer
    Gennari, A.
    Martini, V.
    Boldorini, R.
    Saggia, C.
    Rossi, V.
    D'Avanzo, F.
    Dodaro, I.
    Gallarotti, E.
    Rua, A.
    Branni, C.
    Stella, A.
    Tassone, A.
    Gioffi, E.
    Maggiora, P.
    Gambaro, A.
    Rampi, A.
    Sica, A.
    Khoso, S.
    Barberis, E.
    Manfredi, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S132 - S132
  • [7] Neoadjuvant therapy in patients with breast cancer
    Untch, Michael
    Stickeler, Elmar
    GYNAKOLOGE, 2018, 51 (07): : 531 - 539
  • [8] Defining the metabolomic profile associated with early cardiotoxicity in patients with breast cancer treated with anthracyclines
    Cocco, D.
    Ferro, E. G.
    Ricci, S.
    Deidda, M.
    Noto, A.
    Madeddu, C.
    Atzori, F.
    Scarlozzi, M.
    Mercuro, G.
    Dessalvi, C. Cadeddu
    EUROPEAN HEART JOURNAL, 2020, 41 : 3289 - 3289
  • [9] Pathologic Response to Neoadjuvant Treatment and Biomarker Profile in a Breast Cancer Cohort
    McCarthy, A. J.
    Ryan, C. E.
    Fleming, C.
    Corrigan, M.
    Feeley, L.
    Bennett, M. W.
    Browne, T. J.
    O'Connell, F.
    JOURNAL OF PATHOLOGY, 2015, 237 : S32 - S32
  • [10] Correlation between brain metabolism and headache in early breast cancer patients candidate for neoadjuvant chemotherapy
    Antunovic, L.
    Artesani, A.
    De Sanctis, R.
    Pini, C.
    Benvenuti, C.
    Jacobs, F.
    Gaudio, M.
    Vigano, A.
    Santoro, A.
    Chiti, A.
    Morbelli, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S253 - S254
12345